A carregar...
Advanced Squamous Cell Carcinoma of the Lung: Current Treatment Approaches and the Role of Afatinib
Options for the treatment of squamous cell lung carcinoma expanded in recent years with the introduction of the immune checkpoint inhibitors into routine clinical practice in both the first- and second-line settings but are still limited. As a result, pembrolizumab, given either alone or in combinat...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7519820/ https://ncbi.nlm.nih.gov/pubmed/33061419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S250446 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|